Preparation, characterization and optimization of egg albumin nanoparticles as low molecular-weight drug delivery vehicle

Particle and Particle Systems Characterization

Volumn 29, Issue 3, 2012, Pages 211-222

  Taheri, Elham Sadat ^a,b   Jahanshahi, Mohsen ^a   Mosavian, Mohammad Taghi Hamed ^b,c  

^a BABOL NOSHIRVANI UNIVERSITY OF TECHNOLOGY   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

^c FERDOWSI UNIVERSITY OF MASHHAD   (Iran)

Author keywords

coacervation method; drug delivery; egg albumin; nanoparticle; taguchi method

Indexed keywords

AGITATION SPEED; ALBUMIN NANOPARTICLES; ANTICANCER DRUG; COACERVATION METHOD; DRUG DELIVERY APPLICATIONS; DRUG DELIVERY VEHICLES; EGG ALBUMIN; INFLUENCING FACTOR; NANOPARTICLE SIZES; OPTIMUM CONDITIONS; PH VALUE; SYNTHESIS PARAMETERS; TAGUCHI ANALYSIS;

ATOMIC FORCE MICROSCOPY; DRUG DELIVERY; FACTOR ANALYSIS; NANOPARTICLES; OLIGONUCLEOTIDES; OPTIMIZATION; PHOTON CORRELATION SPECTROSCOPY; SURFACE PROPERTIES; TAGUCHI METHODS;

SYNTHESIS (CHEMICAL);

EID: 84864775110     PISSN: 09340866     EISSN: 15214117     Source Type: Journal    
DOI: 10.1002/ppsc.201100037     Document Type: Article

References (44)

1. B. Irving, Nanoparticle drug delivery system. Innovations in pharmaceutical Technology 2007, 58-62.
2. J. Panyam, V. Labhasetwar, Biodegradable nanoparticles for drug and gene delivery to cell and tissue. Adv. Drug Deliv. Rev. 2003, 52, 329-347. (Pubitemid 36297053)
3. R. Mehravar, M. Jahanshahi, N. Saghatoleslami, Production of biological nanoparticles from α-Lactalbumin for drug delivery and food science application. Afr. J. Biotechnol. 2009, 8 (24), 6822-6827.
4. V. J. Mohanraj, Y. Chen, Nanoparticles-A Review. Trop. J. Pharm. Res. 2006, 5 (1), 561-573.
5. O. Kayser, A. Lemke, N. Hernandez-Trejo, The Impact of Nanobiotechnology on the Development of New Drug Delivery Systems. Curr. Pharm. Biotechnol. 2005, 6, 3-5. (Pubitemid 40246748)
6. R. Mehravar, M. Jahanshahi, N. Saghatoleslami, Human Serum Albumin (HSA) Nanoparticles as Drug Delivery System: Preparation, Optimization and Characterization Study. Dynamic Biochemistry, Process Biotechnology and Molecular Biology, Global science Books 2009.
7. M. Jahanshahi, Z. Babaei, Protein nanoparticle: A unique system as drug delivery vehicles. Afr. J. Biotechnol. 2008, 7 (25), 4926-4934.
8. M. Jahanshahi, M. H. Sanati, S. Hajizadeh, Z. Babaei, Gelatin nanoparticle fabrication and optimization of the particle size. Phys. Stat. sol. (a) 2008, 1-5.
9. P. Li, Y. N. Dai, J. P. Zhang, A. Q. Wang, Q. Wei, Chitosan-alginate nanoparticles as a novel drug delivery system for nifedipine. Int. J. Biomed. Sci. 2008, 4, 141-151.
10. P. V. Kumar, N. K. Jain, Suppression of Agglomeration of Ciprofloxacin- Loaded Human Serum Albumin Nanoparticles. AAPS Pharm. Sci. Technol. 2007, 8 (1), Article 17.
11. J. Kreuter, Nanoparticulate systems in drug delivery and targeting. J. Drug Targ. 1995, 3, 171-173.
12. C. Weber, C. Coester, J. Kreuter, K. Langer, Desolvation process and surface characterization of protein nanoparticles. Int. J. Pharm. 2000, 194, 91-102.
13. M. Jahanshahi, S. Williams, A. Lyddiatt, S. A. Shojaosadati, Preparation and purification of synthetic protein nanoparticulates. J. IEE Proc-Nanobiotechnol. 2004, 151 (5), 176-182.
14. C. Coester, P. Nayyar, J. Samuel, In vitro uptake of gelatin nanoparticles by murine dendritic cells and their intracellular localization. Eur. J. Pharm. Biopharm. 2006, 62, 306-314. (Pubitemid 43356580)
15. W. Lin, G. A. Coombes, C. Garnett, C. Davies, E. Schacht, S. Davis, L. Illun, Preparation of sterically stabilized human serum albumin nanosphere using a novel dextranox-MPEG crosslinking agent. Pharm. Res. 1994, 11, 1588-1592. (Pubitemid 24339679)
16. S. S. Kumaresh, M. A. Tejraj, R. K. Anandrao, E. R. Walter, Biodegradable polymeric nanoparticles as drug delivery devices. J. Control. Release. 2001, 70, 1-20.
17. B. Muller, H. Leuenberger, T. Kissel, Albumin nanospheres as carriers for passive drug targeting: an optimized manufacturing technique. Pharm. Res. 1996, 13 (1), 32-37. (Pubitemid 26076293)
18. J. Lazko, Y. Popineau, J. Legrand, Soy glycine microcapsules by simple coacervation method. Colloids Surf. B: Biointerfaces. 2004, 37, 1-8. (Pubitemid 39164187)
19. L. B. Peppas, Recent advances on the use of biodegradable microparticles and nanoparticles in controlled drug delivery. Int. J. Pharm. 1995, 116, 1-9.
20. J. Heller, R. W. Baker, Theory and practice of controlled release of bioactive materials, In: Baker RW(Ed) Controlled Release of Bioactive Materials. Academic press. New York. pp 1980, 1-17.
21. Y. Masumura, H. Maeda, A new concept for macromolecular therapeutics in cancer chemotherapy: Mechanism of tumoritropic accumulation of proteins of the antitumor agent smances. Cancer Res. 1986, 46, 6387-6392. (Pubitemid 17221789)
22. Y. Takakura, T. Fujita, M. Hashida, H. Sezaki, Diposition characteristics of macromolecules in tumir-bearing mice. Pharm. Res. 1990, 7, 339-346. (Pubitemid 20266586)
23. J. M. Liu, P. Y. Lu, W. K. Weng, Studies on modifications of ITO surfaces in OLED devices by Taguchi methods. Mater. Sci. Eng. B. 2001, 85, 209-221.
24. S. K. Park, K. D. Kim, H. T. Kim, Preparation of silica nanoparticles: determination of the optimal synthesis conditions for small and uniform particles. Colloids Surf. A: Physicochem. Eng. Aspects. 2000, 197, 7-17. (Pubitemid 34017362)
25. K. Arun, K. shakti, K. K. Aggarwal, Identification of strategy parameters for particle swarm optimizer through Taguchi method. j. Zhejiang. University-Sci. A. 2006, 7 (12), 1989-1994. (Pubitemid 46022164)
26. H. Atil, Y. Unver, A different approach of experimental design: Taguchi method. Pak. J. Biology. sci. 2000, 3, 1538-1540.
27. M. Jahanshahi, M. H. Sanati, Z. Babaei, Optimization of parameters for the fabrication of gelatin nanoparticles by the Taguchi robust design method. J. Applied Statistics. 2008, 35, 1345-1353.
28. R. D. Yang, R. R. Mather, A. F. Fortheringham, The application of factorial experimental design to the processing of polypropylene fibres. J. Mater. Sci. 2001, 36, 3097-3101. (Pubitemid 32680807)
29. K. Langer, S. Balthasar, V. Vogel, N. Dinauer, H. V. Briesen, D. Schubert, Optimization of the preparation process for human serum albumin (HSA) nanoparticle. Int. J. Pharm. 2003, 257, 169-180. (Pubitemid 36507043)
30. M. Jahanshahi, authore, Molecular Nanotechnology and Nanobiotechnology, Book: Academic University (Mazandaran) publications. ISBN: 964-2571-10-2 2007.
31. J. Panyam, V. Labhasetwar, Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv. Drug Del. Rev. 2003, 55, 329-47. (Pubitemid 36297053)
32. M. P. Desai, V. Labhasetwar, E. Walter, R. J. Levy, G. L. Amidon, The mechanism of uptake of biodegradable microparticles in Caco-2 cells is size dependent. Pharm. Res. 1997, 14, 1568-1573. (Pubitemid 28009208)
33. W. Zauner, N. A. Farrow, A. F. Haines, In vitro uptake of polystyrene microspheres: effect of particles size, cell line and cell density. J. Controlled Release 2001, 71, 39-51. (Pubitemid 32195440)
34. J. Kreuter, Peroral administration of nanoparticles. Adv. Drug Del. Rev. 1991, 7 (1), 71-86.
35. J. Kreuter, P. Ramge, V. Petrov, S. Hamm, S. E. Gelperina, B. Engelhardt, R. Alyautdin, H. von Briesen, D. J. Begley, Direct evidence that polysorbate-80-coated poly (butylcyanoacrylate) nanoparticles deliver drugs to the CNS via specific mechanisms requiring prior binding of drug to the nanoparticles. Pharm. Res. 2003, 20, 409-416. (Pubitemid 36288370)
36. H. M. Redhead, S. S. Davis, L. Illum, Drug delivery in poly (lactide-co-glycolide) nanoparticles surface modified with poloxamer 407 and poloxamine 908: in vitro characterisation and in vivo evaluation. J. Control. elease. 2001, 70, 353-363. (Pubitemid 32155458)
37. B. Muller, H. Leuenberger, T. Kissel, Albumin nanospheres as carriers for passive drug targeting: an optimized manufacturing technique. Pharm. Res. 1996, 13 (1), 32-37. (Pubitemid 26076293)
38. M. Rahimnejad, M. Jahanshahi, Gh. Najafpour, Production of biological nanoparticles from bovine serum albumin for drug delivery. Afr. J. Biotechnol. 2006, 5 (20), 1918-1923. (Pubitemid 44736967)
39. M. Jahanshahi, M. H. Sanati, Z. Minuchehr, S. Hajizade, Z. Babaei, Controlled fabrication of gelatin nanoparticle as drug carrier. Nanotechnology and its Application. American Institute of physics. 2007, 929, 228.
40. M. Jahanshahi, A. W. Pacek, A. W. Nienow, A. Lyddiatt, Fabrication by three-phase emulsification of pellicular adsorbent customized for liquid fluidized bed adsorption products. J. Chem. Technol. Biotechnol. 2003, 78, 1111-1120. (Pubitemid 37294882)
41. G. Owen Jones, A. Eric Decker, D. J. McClements, Comparison of protein-polysaccharide nanoparticles fabrication methods: Impact of biopolymer complexation befor or after particle formation. J. Colloid Interface Sci. 2010, 344, 21-29.
42. A. Kumari, S. K. Yadav, S. C. Yadav, Biodegradable polymeric nanoparticles based drug delivery systems. Colloid surf. B:Biointerface. 2010, 75, 1-18.
43. D. Barreca, G. Lagana, S. Ficarra, E. Tellone, U. Leuzzi, S. Magazu, A. Galtieri, E. Belleco, Anti-aggregation properties of terhalos on heat induced secondary structure and conformation changes of bovin serum albumin. Biophys. Chem. 2010, 147 (3), 146-152.
44. P. Esmaeilzadeh, Z. Fakhroueian, M. Jahanshahi, M. Chamani, H. R. Zamanizadeh, B. Rasekh, A Synthetic Garden of State of the Art Natural Protein Nanoarchitectures Dispersed in Nanofluids. J. Biomed. Nanotechnol. 2011, 7, 433-440.